Identification and characterization of cytochrome P4502D656B (CYP2D656B), a novel allele associated with the poor metabolizer phenotype.

被引：0

作者：

Gaedigk, A. ^{[1
]}

Eklund, J. D. ^{[1
]}

Pearce, R. E. ^{[1
]}

Leeder, J. S. ^{[1
]}

Alander, S. W. ^{[1
]}

Bradford, L. D. ^{[1
]}

Kennedy, M. J. ^{[1
]}

机构：

[1] Univ Louisville, Childrens Mercy Hosp, Morehouse Sch Med, Kansas City, MO USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 81卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：S85 / S85

页数：1

共 50 条

[41] Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotypes [J].

Daly, AK ;

Fairbrother, KS ;

Andreassen, OA ;

London, SJ ;

Idle, JR ;

Steen, VM .

PHARMACOGENETICS, 1996, 6 (04) :319-328

[42] The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes - Author's commentary [J].

Tucker, GT .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (07) :S748-S749

[43] Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D6*42, in African American subjects [J].

Gaedigk, A ;

Ndjountché, L ;

Gaedigk, R ;

Leeder, JS ;

Bradford, LD .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (06) :575-576

[44] Cytochrome P450 2D6 and schizophrenia.: Is the frequent CYP2D6*2 allele protective? [J].

Meary, A. ;

Loriot, M. A. ;

Brousse, G. ;

Szoke, A. ;

Schurhoff, F. ;

Lancon, C. ;

Llorca, P. M. ;

Broly, F. ;

Beaune, P. ;

Leboyer, M. .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 :56-56

[45] Identification of a novel non-functional CYP2D6 allele, 2D6*42, in African Americans [J].

Gaedigk, A ;

Ndjountche, L ;

Bradford, LD ;

Leeder, JS .

DRUG METABOLISM REVIEWS, 2002, 34 :151-151

[46] Identification of a Novel CYP2D7:CYP2D6 Hybrid Resulting in a Null Genetic Phenotype [J].

Butz, K. G. ;

Murphy, M. P. .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06) :624-624

[47] CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction [J].

Gaedigk, Andrea ;

Fuhr, Uwe ;

Johnson, Charlene ;

Berard, L. Anick ;

Bradford, DiAnne ;

Leeder, J. Steven .

PHARMACOGENOMICS, 2010, 11 (01) :43-53

[48] The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation [J].

Zimmermann, Tim ;

Hoppe-Lotichius, Maria ;

Koerner, Andreas ;

Lautem, Anja ;

Heise, Michael ;

Foltys, Daniel ;

Weiler, Nina ;

Biesterfeld, Stefan ;

Schmidtmann, Irene ;

Galle, Peter R. ;

Otto, Gerd ;

Schuchmann, Marcus .

TRANSPLANT INTERNATIONAL, 2011, 24 (11) :1059-1067

[49] A MISSENSE MUTATION IN EXON-6 OF THE CYP2D6 GENE LEADING TO A HISTIDINE-324 TO PROLINE EXCHANGE IS ASSOCIATED WITH THE POOR METABOLIZER PHENOTYPE OF SPARTEINE [J].

EVERT, B ;

GRIESE, EU ;

EICHELBAUM, M .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1994, 350 (04) :434-439

[50] The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report [J].

Kuzin, Maxim ;

Scharrer, Isabel ;

Nolan, Daniele ;

Baumgartner, Markus ;

Paulzen, Michael ;

Schoretsanitis, Georgios ;

Xepapadakos, Franziskos .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 (04) :354-357

← 1 2 3 4 5 →

Identification and characterization of cytochrome P4502D6*56B (CYP2D6*56B), a novel allele associated with the poor metabolizer phenotype.

Identification and characterization of cytochrome P4502D656B (CYP2D656B), a novel allele associated with the poor metabolizer phenotype.